Stock Screener App

Frei -

Installieren

12.83

7.82% 0.93

after-market

Handel nachbörslich: 12.83

Trevi Therapeutics Inc (TRVI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Trevi Therapeutics Inc-Aktie (TRVI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	37.53% 20.51	14.91	10.22	13.92	13.72
Operating Income/Loss	37.53% -20.51	-14.91	-10.22	-13.92	-13.72
Nonoperating Income/Loss	58.41% 2.693	1.70	1.888	2.099	1.40
Income/Loss From Continuing Operations Before Tax	34.85% -17.82	-13.21	-8.332	-11.82	-12.32
Income Tax Expense/Benefit	5.00% -0.019	-0.02	-0.016	-0.015	-0.021
Net Income/Loss	34.91% -17.80	-13.19	-8.316	-11.80	-12.30
Basic Average Shares	7.56% 156.60	145.59	-	145.10	130.35
Diluted Average Shares	7.56% 156.60	145.59	-	145.10	130.35
Basic Earnings Per Share	22.22% -0.11	-0.09	-	-0.08	-0.09
Diluted Earnings Per Share	22.22% -0.11	-0.09	-	-0.08	-0.09

BRVE

$20.27

5.52%

ZBIO

$28.18

5.50%

SEPN

$39.35

8.16%

VIR

$10.74

5.19%

MAZE

$32.45

9.26%

XNCR

$24.94

7.55%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters